TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
1.780
+0.020 (1.14%)
Sep 13, 2024, 9:45 AM EDT - Market open
TherapeuticsMD Market Cap
TherapeuticsMD has a market cap or net worth of $20.53 million as of September 13, 2024. Its market cap has decreased by -48.68% in one year.
Market Cap
20.53M
Enterprise Value
23.00M
1-Year Change
-48.68%
Ranking
Category
Stock Price
$1.78
Market Cap Chart
Since March 27, 2012, TherapeuticsMD's market cap has decreased from $210.70M to $20.53M, a decrease of -90.26%. That is a compound annual growth rate of -17.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2024 | 20.50M | -13.87% |
| Dec 29, 2023 | 23.80M | -55.01% |
| Dec 30, 2022 | 52.90M | -64.99% |
| Dec 31, 2021 | 151.10M | -54.23% |
| Dec 31, 2020 | 330.10M | -49.70% |
| Dec 31, 2019 | 656.20M | -27.60% |
| Dec 31, 2018 | 906.30M | -30.67% |
| Dec 29, 2017 | 1.31B | 15.24% |
| Dec 30, 2016 | 1.13B | -38.50% |
| Dec 31, 2015 | 1.84B | 165.63% |
| Dec 31, 2014 | 694.30M | -8.08% |
| Dec 31, 2013 | 755.30M | 144.20% |
| Dec 31, 2012 | 309.30M | 46.80% |
| Mar 27, 2012 | 210.70M | - |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Renalytix | 21.07M |
| Lipocine | 20.96M |
| MIRA Pharmaceuticals | 20.84M |
| HCW Biologics | 20.81M |
| Inspira Technologies Oxy B.H.N. | 20.72M |
| MEI Pharma | 20.12M |
| NKGen Biotech | 20.10M |
| Nephros | 19.88M |